glp 1 это Эволюция агонистов рецепторов глюкагоноподобного пептида-1 в терапии сахарного диабета 2 типа | Галстян GLP-1's: What They Are and
Description
This paper reviews the evidence related to oral semaglutide decreasing cardiovascular risk in patients with type 2 diabetes, focusing on the drugs antiatherosclerotic properties

A new real-world study presented at the ASMBS 2025 Annual Meeting compares outcomes between GLP-1 medications (such as semaglutide and tirzepatide) and bariatric surgery

Long-acting amylin analog peptide

Companies awaiting CV outcomes trial, and court decision in patent case

The Food and Drug Administration's approval of a Wegovy pill, the first ever oral GLP-1 medication on Dec
The Good Kitchen takes the guesswork out of what should I eat? Our rotating menu is chef-crafted and dietitian-approved, designed to support metabolic health with balanced meals that taste great and feel good
